Table 1.
Clinical and Morphology Characteristics Between pCR and Non-pCR Group
| Characteristics | pCR (n=54) | Non-pCR (n=73) | p value |
|---|---|---|---|
| Age,mean(SD),Y | 52.80±9.24 | 50.62±11.19 | 0.309 |
| Menonpausal status | 0.278 | ||
| Premenopaual | 15(27.78%) | 26(35.61%) | |
| Postmenopaal | 39(72.22%) | 47(64.39%) | |
| Enhancement pattern | 0.299 | ||
| Mass | 36(66.67%) | 53(72.60%) | |
| Non-mass | 18(33.33%) | 20(27.40%) | |
| Multifocal or multicenter | 0.242 | ||
| Present | 42(77.78%) | 53(72.60%) | |
| Absent | 12(22.22%) | 20(27.40%) | |
| Pre-NAC T stage | 0.468 | ||
| T2 | 40(74.07%) | 53(72.60%) | |
| T3 | 14(25.93%) | 20(27.40%) | |
| Pre-NAC N stage | 0.211 | ||
| N0 | 16(29.63%) | 23(31.50%) | |
| N1 | 29(53.70%) | 38(52.05%) | |
| N2 | 5(9.26%) | 2(2.74%) | |
| N3 | 4(7.41%) | 10(13.71%) |
Abbreviations: NAC, neoadjuvant chemotherapy; PCR, pathological complete response; SD, standard deviation.